BlueLight Therapeutics
Burlingame
About BlueLight Therapeutics
BlueLight Therapeutics uses a proprietary structure-based platform to discover small molecules against difficult-to-drug targets. BlueLight Therapeutics leverages a proprietary, structure-driven platform to develop novel therapeutic molecules against challenging, high-value drug targets. The company has a passionate and experienced team with unique expertise on developing structural assays across a broad range of target classes.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $46.6M
- Funding stage: Late Stage Venture
- Last round: Series C (Sep 2018)
- Website: bluelighttx.com
- Phone: (650) 871-8716
Industries & Categories
Biotechnology, Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/bluelight-therapeutics-75162 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.